Quick Takeaways
- Thomas A. Satterfield Jr. filed SCHEDULE 13G/A for OS Therapies Incorporated Common Stock, par value $0.001 per share (OSTX).
- Disclosed ownership: 5.9%.
- Date of event: 31 Dec 2024.
Thomas A. Satterfield Jr. - 31 Dec 2024 SCHEDULE 13G/A Report for OS Therapies Incorporated Common Stock, par value $0.001 per share (OSTX)
- Filing Manager
- Thomas A. Satterfield Jr.
- Reporting Manager
- Thomas A. Satterfield, Jr.
- Symbol
- OSTX
- Shares outstanding
- 21,482,458 shares
- Disclosed Ownership
- 1,267,465 shares
- Ownership
- 5.9%
- Form type
- SCHEDULE 13G/A
- Filing time
- 12 Feb 2025, 08:02:14 UTC
- Date of event
- 31 Dec 2024
- Next filing
- 13 Aug 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Thomas A. Satterfield Jr. disclosed 5.9% ownership in OS Therapies Incorporated Common Stock, par value $0.001 per share (OSTX) on 31 Dec 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 12 Feb 2025, 08:02.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Thomas A. Satterfield, Jr. | 5.9% | 1,267,465 | 61,215 | 1,206,250 | /s/ Thomas A. Satterfield, Jr. | Thomas A. Satterfield, Jr. |